C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients.
Zhang Y, Lu L, He Z, Xu Z, Xiang Z, Nie RC, Lin W, Chen W, Zhou J, Yin Y, Xie J, Zhang Y, Zheng X, Zhu T, Cai X, Li P, Chao X, Cai MY.
Zhang Y, et al. Among authors: li p.
Front Immunol. 2022 Feb 4;13:808101. doi: 10.3389/fimmu.2022.808101. eCollection 2022.
Front Immunol. 2022.
PMID: 35185894
Free PMC article.